Lifecore Biomedical, Inc. LFCR Business Segments
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| CDMO | $90.1M-5.8% | $95.67M-1.6% | $97.19M+2.0% | $95.26M-1.4% | |
| HA manufacturing | $38.77M+11.9% | $34.64M+2.9% | $33.67M+1.5% | $33.19M+4.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Lifecore Biomedical, Inc. break its business down?
- Lifecore Biomedical, Inc. (LFCR) reports revenue by product across 2 parts — CDMO and HA manufacturing. Each is extracted from the segment footnotes and tracked over time.
- Where does Lifecore Biomedical, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Lifecore Biomedical, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
